|
Volumn 3, Issue 4, 2001, Pages 15-26
|
Epidemiology and pathophysiology of Alzeimer's disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMYLOID BETA PROTEIN;
AMYLOID BETA PROTEIN VACCINE;
ANTIINFLAMMATORY AGENT;
ANTIOXIDANT;
BETA SECRETASE INHIBITOR;
ENZYME INHIBITOR;
GAMMA SECRETASE INHIBITOR;
UNCLASSIFIED DRUG;
VACCINE;
AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;
APOLIPOPROTEIN E;
ADULT;
AGED;
AGING;
ALZHEIMER DISEASE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CAREGIVER;
CLINICAL FEATURE;
CLINICAL RESEARCH;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEMENTIA;
DEMOGRAPHY;
DRUG THERAPY;
EPIDEMIOLOGY;
GENE MUTATION;
HEALTH CARE SYSTEM;
HUMAN;
IMMUNIZATION;
MODEL;
MOUSE;
NONHUMAN;
PATHOLOGY;
PATHOPHYSIOLOGY;
PATIENT CARE;
POLICY;
POPULATION;
PREDICTION;
TREATMENT OUTCOME;
UNITED STATES;
AGE DISTRIBUTION;
BIOLOGICAL MODEL;
GENETIC MARKER;
GENETICS;
METABOLISM;
NEUROFIBRILLARY TANGLE;
PHYSIOLOGY;
REVIEW;
SENILE PLAQUE;
AGE DISTRIBUTION;
AGED;
AGED, 80 AND OVER;
ALZHEIMER DISEASE;
APOLIPOPROTEINS E;
GENETIC MARKERS;
HUMANS;
MODELS, NEUROLOGICAL;
NEUROFIBRILLARY TANGLES;
NEUROTRANSMITTER AGENTS;
SENILE PLAQUES;
|
EID: 0034958224
PISSN: 10983597
EISSN: None
Source Type: Journal
DOI: 10.1016/S1098-3597(01)90045-6 Document Type: Article |
Times cited : (28)
|
References (17)
|